A systems biology and proteomics-based approach identifies SRC and VEGFA as biomarkers in risk factor mediated

Alexandar V1, Pradeep G Nayar2, R Murugesan1

  • 1Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Kelambakkam 603 103, Tamil Nadu, India.

Molecular Biosystems
|June 10, 2016
PubMed

Insights

A systems biology approach identified novel molecular signatures and serum biomarkers for coronary heart disease (CHD). These findings link traditional risk factors to CHD pathophysiology, aiding in diagnosis.

Area of Science:

  • Cardiovascular Research
  • Systems Biology
  • Molecular Medicine

Background:

  • Coronary heart disease (CHD) is a leading global cause of mortality, exacerbated by risk factors like smoking, hypertension, obesity, and diabetes.
  • The precise molecular mechanisms linking these risk factors to CHD remain incompletely understood due to disease complexity and a lack of integrative analysis.

Purpose of the Study:

  • To develop a novel systems biology approach to elucidate the molecular mechanisms underlying CHD risk factors.
  • To identify potential diagnostic biomarkers for CHD by integrating genetic, protein interaction, and pathway data.

Main Methods:

  • Literature mining to identify causative genes for CHD and risk factors.
  • Construction and analysis of protein-protein interaction networks to find common molecular signatures.
  • Mapping signatures to tissue networks to identify functional modules and candidate biomarkers (SRC, VEGFA, HIF1A).
  • Validation of candidate biomarkers (SRC, VEGFA, HIF1A) alongside existing markers (CRP, NOS3, VCAM1) using ELISA in patient and control serum samples.

Main Results:

  • A sub-network of 82 proteins and key functional modules (AKT/p13k, MAPK, wnt pathways) were identified.
  • SRC, VEGFA, and HIF1A were prioritized as potential diagnostic markers.
  • SRC, VEGFA, HIF1A, CRP, and NOS3 showed significant alterations in CHD patients compared to controls.

Conclusions:

  • The study highlights the influence of traditional risk factors on CHD pathophysiology through identified molecular pathways.
  • Validated serum markers (SRC, VEGFA, HIF1A, CRP, NOS3) show promise for improving CHD diagnosis.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
717
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
915
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
817